StockData
biote Corp. logo

biote Corp. (BTMD) company profile

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3070% below fair value
$0.99+0.03 (+3.09%)

Close on Nov 17, 2026Market cap $35.57MP/E 9.9Yield –

About biote

Medicinal Chemicals & Botanical Products, SIC 2833

biote Corp. operates in the wellness and healthcare sector, developing and providing the Biote Method along with Biote-branded dietary supplements and convenience kits. The company provides training programs and methodology for medical clinics and practitioners, allowing prescribers to offer compounded bioidentical hormone pellets, supplements, and related procedures to their patients. In addition to delivering clinical training services and contract term services, the business supports the sale and distribution of dietary supplements, disposable trocars, and procedure-related supplies directly to partnered clinics and certified healthcare professionals.

The company conducts its business primarily within the United States while also engaging in sales across Mexico and other foreign locations. Its commercial operations rely on a network of Biote-partnered clinics and Biote-certified practitioners concentrated in particular geographic regions. biote Corp. is incorporated in the state of Delaware, maintaining its principal executive offices and corporate headquarters in Irving, Texas.

Summary of the business section of biote's latest annual report, written by StockData.

Company profile

Company

Legal name
biote Corp.
Headquarters
Irving, TX
Address
1875 W. Walnut Hill Ln #100 75038
Phone
(972) 486-9346
Website
biote.com
Employees
223, Dec 31, 2025
Industry
Medicinal Chemicals & Botanical Products
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, Dallas, Texas

Stock & identifiers

Ticker
BTMD
Former tickers
HYAC until May 27, 2022
Exchange
Nasdaq
IPO date
Mar 3, 2021
Shares outstanding
36M, Aug 5, 2026
Public float
$97.90M, Jun 30, 2025
Filer category
Accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
1819253
CUSIP
090683103
ISIN
US0906831039
FIGI
BBG00ZCMCB75
Share class FIGI
BBG00ZCMCC37
EIN
85-1791125

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Marc D. BeerExecutive Chairman, Director239,744
Robert Charles PetersonInterim CEO, Director0
Daniel Michael MonicoGeneral Counsel1
Mary Elizabeth ConlonGeneral Counsel140,393
Bret ChristensenDirector37,595
Andrew R. HeyerDirector2,292,156
Dana Lynn JacobyDirector63,964
Stephen Mark ConeDirector160,829
Debra L. MorrisDirector71,562
Richard R. BarreraDirector4,622,748
Steven J. HeyerDirector729,856

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsOption awardsOtherTotalvs. prior year
Bret Christensen
Chief Executive Officer
$642.31K–$3.95M$359.98K$66.96K$5.02M–
Teresa S. Weber
Former Chief Executive Officer
$86.16K–––$859.75K$945.91K-75%
Robert Peterson
Chief Financial Officer and Chief Business Officer
$458.87K–$778.91K$205.33K$11.42K$1.45M-18%
Mary Elizabeth Conlon
Former Vice President, Business Development, General Counsel and Corporate Secretary
$439.90K$170.23K–$396.13K$664.78K$1.67M+41%
Marc Beer
Non-Executive Chairman, Former Executive Chairman
$156.93K–$1.10M$104.42K$42.50K$1.41M-47%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Mar 3, 2021
Offer price
$10.00
Securities offered
30,000,000
Gross proceeds
$300.00M
Exchange
Nasdaq
First trading day
Apr 28, 2021
First-day close
$10.05+0.5%
Lock-up ends (est.)
Oct 25, 2021

“Each unit has an offering price of $10.00 and consists of one share of Class A common stock and one-fourth of one redeemable warrant.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 223 employees, across 11 departments.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?